Andrea Mastropietro

Marianna Maranghi, Aris Anagnostopoulos, Irene Cannistraci et al. · eth-zurich

The Associazione Medici Diabetologi (AMD) collects and manages one of the largest worldwide-available collections of diabetic patient records, also known as the AMD database. This paper presents the initial results of an ongoing project whose focus is the application of Artificial Intelligence and Machine Learning techniques for conceptualizing, cleaning, and analyzing such an important and valuable dataset, with the goal of providing predictive insights to better support diabetologists in their diagnostic and therapeutic choices.

Gianluca De Carlo, Andrea Mastropietro, Aris Anagnostopoulos

Graph neural networks (GNNs) excel in learning from network-like data but often lack interpretability, making their application challenging in domains requiring transparent decision-making. We propose the Graph Kolmogorov-Arnold Network (GKAN), a novel GNN model leveraging spline-based activation functions on edges to enhance both accuracy and interpretability. Our experiments on five benchmark datasets demonstrate that GKAN outperforms state-of-the-art GNN models in node classification, link prediction, and graph classification tasks. In addition to the improved accuracy, GKAN's design inherently provides clear insights into the model's decision-making process, eliminating the need for post-hoc explainability techniques. This paper discusses the methodology, performance, and interpretability of GKAN, highlighting its potential for applications in domains where interpretability is crucial.

Paola Stolfi, Andrea Mastropietro, Giuseppe Pasculli et al.

Gene-disease associations are fundamental for understanding disease etiology and developing effective interventions and treatments. Identifying genes not yet associated with a disease due to a lack of studies is a challenging task in which prioritization based on prior knowledge is an important element. The computational search for new candidate disease genes may be eased by positive-unlabeled learning, the machine learning setting in which only a subset of instances are labeled as positive while the rest of the data set is unlabeled. In this work, we propose a set of effective network-based features to be used in a novel Markov diffusion-based multi-class labeling strategy for putative disease gene discovery. The performances of the new labeling algorithm and the effectiveness of the proposed features have been tested on ten different disease data sets using three machine learning algorithms. The new features have been compared against classical topological and functional/ontological features and a set of network- and biological-derived features already used in gene discovery tasks. The predictive power of the integrated methodology in searching for new disease genes has been found to be competitive against state-of-the-art algorithms.